Facial Basal Cell Carcinoma Treated with Topical 5% Imiquimod Cream with Dermoscopic Evaluation

Basal cell carcinoma (BCC) is the most common skin cancer worldwide. Surgical excision is considered to be the primary therapeutic modality wherever possible. For inoperable cases, 5% imiquimod seems to be a good alternative. We present two cases of nodular pigmented BCCs on the face in elderly wome...

Descripción completa

Detalles Bibliográficos
Autores principales: Singal, Archana, Daulatabad, Deepashree, Pandhi, Deepika, Arora, VK
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924409/
https://www.ncbi.nlm.nih.gov/pubmed/27398014
http://dx.doi.org/10.4103/0974-2077.184040
_version_ 1782439869959634944
author Singal, Archana
Daulatabad, Deepashree
Pandhi, Deepika
Arora, VK
author_facet Singal, Archana
Daulatabad, Deepashree
Pandhi, Deepika
Arora, VK
author_sort Singal, Archana
collection PubMed
description Basal cell carcinoma (BCC) is the most common skin cancer worldwide. Surgical excision is considered to be the primary therapeutic modality wherever possible. For inoperable cases, 5% imiquimod seems to be a good alternative. We present two cases of nodular pigmented BCCs on the face in elderly women successfully treated with 5% imiquimod cream application resulting in complete clinical clearance of lesion as well as on histology and dermatoscopy. There was no recurrence of the lesion on 2 years follow-up for the first and 1.5 years for the second patient.
format Online
Article
Text
id pubmed-4924409
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-49244092016-07-08 Facial Basal Cell Carcinoma Treated with Topical 5% Imiquimod Cream with Dermoscopic Evaluation Singal, Archana Daulatabad, Deepashree Pandhi, Deepika Arora, VK J Cutan Aesthet Surg Case Report Basal cell carcinoma (BCC) is the most common skin cancer worldwide. Surgical excision is considered to be the primary therapeutic modality wherever possible. For inoperable cases, 5% imiquimod seems to be a good alternative. We present two cases of nodular pigmented BCCs on the face in elderly women successfully treated with 5% imiquimod cream application resulting in complete clinical clearance of lesion as well as on histology and dermatoscopy. There was no recurrence of the lesion on 2 years follow-up for the first and 1.5 years for the second patient. Medknow Publications & Media Pvt Ltd 2016 /pmc/articles/PMC4924409/ /pubmed/27398014 http://dx.doi.org/10.4103/0974-2077.184040 Text en Copyright: © 2016 Journal of Cutaneous and Aesthetic Surgery http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Case Report
Singal, Archana
Daulatabad, Deepashree
Pandhi, Deepika
Arora, VK
Facial Basal Cell Carcinoma Treated with Topical 5% Imiquimod Cream with Dermoscopic Evaluation
title Facial Basal Cell Carcinoma Treated with Topical 5% Imiquimod Cream with Dermoscopic Evaluation
title_full Facial Basal Cell Carcinoma Treated with Topical 5% Imiquimod Cream with Dermoscopic Evaluation
title_fullStr Facial Basal Cell Carcinoma Treated with Topical 5% Imiquimod Cream with Dermoscopic Evaluation
title_full_unstemmed Facial Basal Cell Carcinoma Treated with Topical 5% Imiquimod Cream with Dermoscopic Evaluation
title_short Facial Basal Cell Carcinoma Treated with Topical 5% Imiquimod Cream with Dermoscopic Evaluation
title_sort facial basal cell carcinoma treated with topical 5% imiquimod cream with dermoscopic evaluation
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924409/
https://www.ncbi.nlm.nih.gov/pubmed/27398014
http://dx.doi.org/10.4103/0974-2077.184040
work_keys_str_mv AT singalarchana facialbasalcellcarcinomatreatedwithtopical5imiquimodcreamwithdermoscopicevaluation
AT daulatabaddeepashree facialbasalcellcarcinomatreatedwithtopical5imiquimodcreamwithdermoscopicevaluation
AT pandhideepika facialbasalcellcarcinomatreatedwithtopical5imiquimodcreamwithdermoscopicevaluation
AT aroravk facialbasalcellcarcinomatreatedwithtopical5imiquimodcreamwithdermoscopicevaluation

Ejemplares similares